Physician

Shariff Attaya, MD

According to 2025 Medicare claims, Shariff Attaya, MD (NPI: 1770643363) practices cardiac electrophysiology in the Racine-Mount Pleasant, WI market, with the plurality of this provider's patient population coming from Racine, WI. This provider's primary affiliated billing organization is ASCENSION MEDICAL GROUP-SOUTHEAST WISCONSIN INC (NPI: 1609881077; TIN: 391791586) and primary practice location at 53405-1660. Attaya is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Ascension Care Management Health Partners Wisconsin, LLC (ACO ID: A5329), participating under the MSSP model.

Attaya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 571 traditional Medicare patients, billed 2,307 HCPCS/CPT codes, and received $97,628 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 4,862 prescription claims across 809 beneficiaries totaling $2,031,188 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 2 records totaling $45. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $160,734 and ending at $97,628. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $896,446 to $2,031,188. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	827	3,659	$160,734
2016	815	3,526	$141,791
2017	810	3,234	$150,944
2018	679	1,508	$91,854
2019	408	923	$66,652
2020	423	1,156	$60,890
2021	703	2,475	$165,974
2022	667	2,577	$135,270
2023	606	2,396	$108,445
2024	571	2,307	$97,628

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	415	3,584	$896,446
2016	460	3,517	$973,018
2017	511	3,558	$948,861
2018	429	1,848	$497,707
2019	108	266	$78,307
2020	167	705	$191,640
2021	543	2,349	$852,127
2022	626	3,191	$1,138,355
2023	743	4,367	$1,703,816
2024	809	4,862	$2,031,188

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	56	61	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	441	583	$70
93280	Programming of dual lead pacemaker system	92	114	$27
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	121	193	$22
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	293	429	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,362	76,068	$1,484,144
Xarelto	Rivaroxaban	272	16,150	$302,086
Multaq	Dronedarone Hcl	118	6,474	$168,443
Dofetilide	Dofetilide	223	14,559	$25,265
Sotalol	Sotalol Hcl	494	33,762	$11,332

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$45	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shariff Attaya, MD?

Tedicare shows public-source Medicare data for Shariff Attaya, MD (NPI 1770643363), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shariff Attaya, MD have ACO affiliation data?

Shariff Attaya, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Ascension Care Management Health Partners Wisconsin, LLC (MSSP, ACO ID A5329).

What billing organization is linked to Shariff Attaya, MD?

Shariff Attaya, MD is linked to ASCENSION MEDICAL GROUP-SOUTHEAST WISCONSIN INC (billing NPI 1609881077) in the available physician profile data.

Does Shariff Attaya, MD have Open Payments data?

Shariff Attaya, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.